UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Carcinogen found on some medicinal herbs
Research conducted by Seoul Institute of Health and Environment (SIHE) foun...
by Lee Han-soo
|
2017-09-21 11:32
라인
Plastic surgeons’ group issues guideline for patient safety
The Korean Association of Plastic Surgeons (KAPS) has announced a five-poin...
by Lee Han-soo
|
2017-09-20 17:26
라인
AI will be turning point in developing new drugs: report
The domestic pharmaceutical companies need a public artificial intelligence...
by Lee Han-soo
|
2017-09-20 14:59
라인
Samjin gets approval for phase 2 clinical trials for dry eye syndrome
Samjin Pharmaceuticals said Monday that it has received Ministry of Food an...
by Lee Han-soo
|
2017-09-19 18:03
라인
Samsung Bioepis gets nods for phase 3 trials to treat macular degeneration
Samsung Bioepis said Tuesday that it has received Ministry of Food and Drug...
by Lee Han-soo
|
2017-09-19 17:39
라인
Kuhnil Pharmaceuticals succeed in phase 3 clinical trial for Atorvastatin
Kuhnil Pharmaceuticals said Tuesday that it has succeeded in phase 3 clinic...
by Lee Han-soo
|
2017-09-19 14:58
라인
Samsung Medison presents ultrasonic diagnostic equipment results
Visitors view the Crystal Vue Flow, a piece of equipment that provides a cl...
by Lee Han-soo
|
2017-09-18 17:45
라인
Genexin, Handok presents persistent growth hormone clinical trial results
Genexin and Handok have announced the intermediate results of phase 2 clini...
by Lee Han-soo
|
2017-09-18 14:39
라인
Celltrion in controversy over sexual harassment case
Celltrion found itself embroiled in a controversial situation afters CEO Se...
by Lee Han-soo
|
2017-09-15 18:11
라인
Access Bio, PFSCM sign supply agreement for malaria kit
Access Bio said Friday that it has signed a supply agreement of partnership...
by Lee Han-soo
|
2017-09-15 14:52
라인
US agency okays new treatment for relapsed lymphatic cancer
The U.S. Food and Drug Administration (FDA) has granted accelerated approva...
by Lee Han-soo
|
2017-09-15 12:23
라인
Huons to build new office
Huons Global said Wednesday that it plans to move its headquarters and R&D ...
by Lee Han-soo
|
2017-09-15 10:29
라인
‘BIOplus Incheon 2017’ shares product-developing know-how
BIOplus Incheon 2017 successfully finished their second annual global confe...
by Lee Han-soo
|
2017-09-14 11:14
라인
Sillajen stock surges upon clinical trial announcement
The share price of Sillajen, a biopharmaceutical company, has been surging ...
by Lee Han-soo
|
2017-09-12 13:26
라인
Ildong, Olix agree to develop new drugs
Ildong Pharmaceutical and Olix Pharmaceuticals, an RNA interference (RNAi)-...
by Lee Han-soo
|
2017-09-11 17:30
라인
Celltrion presents Herzuma’s clinical results in Europe
Celltrion said Friday that it has presented the results of the clinical saf...
by Lee Han-soo
|
2017-09-11 12:19
라인
Korea, Russia to cooperate on training medical workers
The Ministry of Health and Welfare 보건복지부 said Friday that it has signed an ...
by Lee Han-soo
|
2017-09-08 17:43
라인
Kang Stem, Heraeus Medical to develop anti-arthritis drug
Kang Stem Biotech 강스템바이오텍 said Thursday that it has signed an agreement wit...
by Lee Han-soo
|
2017-09-08 15:25
라인
Vivus, Alvogen sign agreement to market diet treatment in Korea
Alvogen Korea 알보젠코리아, a pharmaceutical company, announced Friday that it ha...
by Lee Han-soo
|
2017-09-08 15:24
라인
Celltrion fined for violating stock regulations
The Fair Trade Commission 공정거래위원회 (FTC) said Thursday that it has fined Cel...
by Lee Han-soo
|
2017-09-07 18:16
-
이전
111
112
113
114
115
116
117
118
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top